3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Primary Myelofibrosis
19
Myeloproliferative Disorders
16
Polycythemia Vera
10
Leukemia
8
Leukemia, Myeloid, Acute
7
Breast Neoplasms
6
Pancreatic Neoplasms
5
Myelodysplastic Syndromes
5
Hematologic Diseases
5
Thrombocythemia, Essential
4
Multiple Myeloma
4
Bone Marrow Diseases
4
Precursor Cell Lymphoblastic Leukemia-Lymphoma
3
Neoplasms
3
Myelodysplastic-Myeloproliferative Diseases
3
Leukemia, Myelomonocytic, Chronic
3
Graft vs Host Disease
3
Thrombocytosis
2
Prostatic Neoplasms
2
Lymphoma, Large B-Cell, Diffuse
2
Lymphoma, Follicular
2
Lymphoma
2
Colorectal Neoplasms
2
Carcinoma, Non-Small-Cell Lung
2
Bronchiolitis Obliterans Syndrome
2
Triple Negative Breast Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Preleukemia
1
Precancerous Conditions
1
Pathologic Complete Response
1
Interventions
Tamoxifen
9
Letrozole
5
Anastrozole
5
Radiotherapy
3
Radiation
3
Neoadjuvant Therapy
3
afimoxifene
2
Trastuzumab
2
Surgical Procedures, Operative
2
Simvastatin
2
Sentinel Lymph Node Biopsy
2
Radiation Dose Hypofractionation
2
Mastectomy, Segmental
2
Lapatinib
2
Gene Expression Profiling
2
trastuzumab biosimilar HLX02
1
telapristone acetate
1
sargramostim
1
polyphenon E
1
pasireotide
1
palbociclib
1
oxybutynin
1
liposomal doxorubicin
1
exemestane
1
Zoledronic Acid
1
UAB 30
1
Tea
1
Sugars
1
Specimen Handling
1
Radiotherapy, Intensity-Modulated
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Carcinoma, Intraductal, Noninfiltrating
×
ruxolitinib
×
Clear all
No trials found.